{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,13]],"date-time":"2026-11-13T06:14:59Z","timestamp":1794550499988,"version":"4.9.1"},"reference-count":200,"publisher":"Georg Thieme Verlag KG","issue":"03","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Semin Liver Dis"],"published-print":{"date-parts":[[2021,8]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>The most concerned issue in the context of drug\/herb-induced chronic cholestasis is vanishing bile duct syndrome. The progressive destruction of intrahepatic bile ducts leading to ductopenia is usually not dose dependent, and has a delayed onset that should be suspected when abnormal serum cholestasis enzyme levels persist despite drug withdrawal. Immune-mediated cholangiocyte injury, direct cholangiocyte damage by drugs or their metabolites once in bile, and sustained exposure to toxic bile salts when biliary epithelium protective defenses are impaired are the main mechanisms of cholangiolar damage. Current therapeutic alternatives are scarce and have not shown consistent beneficial effects so far. This review will summarize the current literature on the main diagnostic tools of ductopenia and its histological features, and the differential diagnostic with other ductopenic diseases. In addition, pathomechanisms will be addressed, as well as the connection between them and the supportive and curative strategies for ductopenia management.<\/jats:p>","DOI":"10.1055\/s-0041-1729972","type":"journal-article","created":{"date-parts":[[2021,6,15]],"date-time":"2021-06-15T22:50:18Z","timestamp":1623797418000},"page":"331-348","source":"Crossref","is-referenced-by-count":28,"title":["Drug-Induced Vanishing Bile Duct Syndrome: From Pathogenesis to Diagnosis and Therapeutics"],"prefix":"10.1055","volume":"41","author":[{"given":"Fernando","family":"Bessone","sequence":"additional","affiliation":[{"name":"Hospital Provincial del Centenario, Facultad de Ciencias M\u00e9dicas, Servicio de Gastroenterolog\u00eda y Hepatolog\u00eda, Universidad Nacional de Rosario, Rosario, Argentina"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nelia","family":"Hern\u00e1ndez","sequence":"additional","affiliation":[{"name":"Cl\u00ednica de Gastroenterolog\u00eda, Hospital de Cl\u00ednicas y Facultad de Medicina, Universidad de la Rep\u00fablica (UdelaR), Montevideo, Uruguay"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mario","family":"Tanno","sequence":"additional","affiliation":[{"name":"Hospital Provincial del Centenario, Facultad de Ciencias M\u00e9dicas, Servicio de Gastroenterolog\u00eda y Hepatolog\u00eda, Universidad Nacional de Rosario, Rosario, Argentina"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marcelo G.","family":"Roma","sequence":"additional","affiliation":[{"name":"Instituto de Fisiolog\u00eda Experimental (CONICET-UNR), Facultad de Ciencias Bioqu\u00edmicas y Farmac\u00e9uticas, Universidad Nacional de Rosario, Rosario, Argentina"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"194","published-online":{"date-parts":[[2021,6,15]]},"reference":[{"issue":"02","key":"ref1","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1002\/hep.1840150212","article-title":"Drug-induced prolonged cholestasis in adults: a histological semiquantitative study demonstrating progressive ductopenia","volume":"15","author":"C Degott","year":"1992","journal-title":"Hepatology"},{"issue":"S 01","key":"ref2","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/S0168-8278(97)82330-6","article-title":"Vanishing bile duct syndrome in drug-induced liver disease","volume":"26","author":"V J Desmet","year":"1997","journal-title":"J Hepatol"},{"issue":"12","key":"ref3","doi-asserted-by":"crossref","first-page":"2405","DOI":"10.1016\/j.biocel.2004.04.011","article-title":"Apoptosis, autophagy, and more","volume":"36","author":"R A Lockshin","year":"2004","journal-title":"Int J Biochem Cell Biol"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"13","DOI":"10.4137\/JCD.S2785","article-title":"Mechanisms of biliary damage","volume":"3","author":"F Yang","year":"2010","journal-title":"J Cell Death"},{"issue":"04","key":"ref5","doi-asserted-by":"crossref","first-page":"934","DOI":"10.1016\/j.jhep.2014.11.027","article-title":"Autophagy and senescence in fibrosing cholangiopathies","volume":"62","author":"Y Nakanuma","year":"2015","journal-title":"J Hepatol"},{"issue":"02","key":"ref6","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1002\/cphy.c120020","article-title":"Apoptosis and necrosis in the liver","volume":"3","author":"M E Guicciardi","year":"2013","journal-title":"Compr Physiol"},{"issue":"02","key":"ref7","first-page":"139","article-title":"Overview of cell death signaling pathways","volume":"4","author":"Z Jin","year":"2005","journal-title":"Cancer Biol Ther"},{"issue":"34","key":"ref8","doi-asserted-by":"crossref","first-page":"4798","DOI":"10.1038\/sj.onc.1209608","article-title":"Extrinsic versus intrinsic apoptosis pathways in anticancer chemotherapy","volume":"25","author":"S Fulda","year":"2006","journal-title":"Oncogene"},{"issue":"06","key":"ref9","doi-asserted-by":"crossref","first-page":"1625","DOI":"10.1096\/fj.08-111005","article-title":"Life and death by death receptors","volume":"23","author":"M E Guicciardi","year":"2009","journal-title":"FASEB J"},{"issue":"04","key":"ref10","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1046\/j.1440-1711.1999.00837.x","article-title":"Cell death induced by the Fas\/Fas ligand pathway and its role in pathology","volume":"77","author":"P Waring","year":"1999","journal-title":"Immunol Cell Biol"},{"issue":"03","key":"ref11","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1038\/cmi.2016.4","article-title":"Adaptive immunity in the liver","volume":"13","author":"Z Shuai","year":"2016","journal-title":"Cell Mol Immunol"},{"issue":"11","key":"ref12","doi-asserted-by":"crossref","first-page":"1518","DOI":"10.1136\/gut.2005.067801","article-title":"Following the TRAIL from hepatitis C virus and alcohol to fatty liver","volume":"54","author":"S C Afford","year":"2005","journal-title":"Gut"},{"issue":"06","key":"ref13","doi-asserted-by":"crossref","first-page":"2263","DOI":"10.1002\/hep.26993","article-title":"Cholangiocyte senescence by way of N-ras activation is a characteristic of primary sclerosing cholangitis","volume":"59","author":"J H Tabibian","year":"2014","journal-title":"Hepatology"},{"issue":"07","key":"ref14","doi-asserted-by":"crossref","first-page":"1688","DOI":"10.1111\/ajt.12271","article-title":"Biliary epithelial senescence and plasticity in acute cellular rejection","volume":"13","author":"J G Brain","year":"2013","journal-title":"Am J Transplant"},{"issue":"02","key":"ref15","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1002\/hep.31067","article-title":"The spectrum of reactive cholangiocytes in primary sclerosing cholangitis","volume":"71","author":"M E Guicciardi","year":"2020","journal-title":"Hepatology"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"e276","DOI":"10.2741\/A923","article-title":"The role of cholangiocytes in the development of chronic inflammatory liver disease","volume":"7","author":"D H Adams","year":"2002","journal-title":"Front Biosci"},{"issue":"11","key":"ref17","doi-asserted-by":"crossref","first-page":"e14037","DOI":"10.1371\/journal.pone.0014037","article-title":"Primary and malignant cholangiocytes undergo CD40 mediated Fas dependent apoptosis, but are insensitive to direct activation with exogenous Fas ligand","volume":"5","author":"E H Humphreys","year":"2010","journal-title":"PLoS One"},{"issue":"13","key":"ref18","doi-asserted-by":"crossref","first-page":"2345","DOI":"10.1096\/fj.01-0088com","article-title":"CD40 activation-induced, Fas-dependent apoptosis and NF-kappaB\/AP-1 signaling in human intrahepatic biliary epithelial cells","volume":"15","author":"S C Afford","year":"2001","journal-title":"FASEB J"},{"issue":"02","key":"ref19","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1055\/s-2007-1007153","article-title":"Dysregulation of apoptosis in the cholangiopathies and cholangiocarcinoma","volume":"18","author":"A Celli","year":"1998","journal-title":"Semin Liver Dis"},{"issue":"31","key":"ref20","doi-asserted-by":"crossref","first-page":"10895","DOI":"10.1073\/pnas.0802702105","article-title":"Death receptor 5 mediated-apoptosis contributes to cholestatic liver disease","volume":"105","author":"K Takeda","year":"2008","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"03","key":"ref21","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1016\/j.ajpath.2014.10.027","article-title":"Functional role of cellular senescence in biliary injury","volume":"185","author":"L Meng","year":"2015","journal-title":"Am J Pathol"},{"issue":"04","key":"ref22","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1002\/path.1729","article-title":"Frequent cellular senescence in small bile ducts in primary biliary cirrhosis: a possible role in bile duct loss","volume":"205","author":"M Sasaki","year":"2005","journal-title":"J Pathol"},{"issue":"01","key":"ref23","doi-asserted-by":"crossref","first-page":"1020","DOI":"10.1038\/s41467-018-03299-5","article-title":"Paracrine cellular senescence exacerbates biliary injury and impairs regeneration","volume":"9","author":"S Ferreira-Gonzalez","year":"2018","journal-title":"Nat Commun"},{"issue":"04","key":"ref24","doi-asserted-by":"crossref","first-page":"1239","DOI":"10.1016\/S0002-9440(10)64074-6","article-title":"Proliferating bile duct epithelial cells are a major source of connective tissue growth factor in rat biliary fibrosis","volume":"158","author":"N Sedlaczek","year":"2001","journal-title":"Am J Pathol"},{"issue":"04","key":"ref25","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1007\/s005340170002","article-title":"Pathology and pathogenesis of intrahepatic bile duct loss","volume":"8","author":"Y Nakanuma","year":"2001","journal-title":"J Hepatobiliary Pancreat Surg"},{"issue":"02","key":"ref26","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1016\/j.jhep.2010.03.008","article-title":"Modulation of the microenvironment by senescent biliary epithelial cells may be involved in the pathogenesis of primary biliary cirrhosis","volume":"53","author":"M Sasaki","year":"2010","journal-title":"J Hepatol"},{"issue":"01","key":"ref27","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1038\/nrm2308","article-title":"The BCL-2 protein family: opposing activities that mediate cell death","volume":"9","author":"R J Youle","year":"2008","journal-title":"Nat Rev Mol Cell Biol"},{"issue":"03","key":"ref28","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1055\/s-2005-916320","article-title":"Effector mechanisms of nonsuppurative destructive cholangitis in graft-versus-host disease and allograft rejection","volume":"25","author":"D H Adams","year":"2005","journal-title":"Semin Liver Dis"},{"issue":"06","key":"ref29","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1038\/nri3839","article-title":"Perforin and granzymes: function, dysfunction and human pathology","volume":"15","author":"I Voskoboinik","year":"2015","journal-title":"Nat Rev Immunol"},{"issue":"06","key":"ref30","first-page":"1725","article-title":"Apoptosis and hepatobiliary disease","volume":"21","author":"T Patel","year":"1995","journal-title":"Hepatology"},{"issue":"03","key":"ref31","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1111\/j.1742-4658.2005.05103.x","article-title":"Calcium, mitochondria and oxidative stress in neuronal pathology. Novel aspects of an enduring theme","volume":"273","author":"C Chinopoulos","year":"2006","journal-title":"FEBS J"},{"issue":"03","key":"ref32","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1016\/0168-8278(90)90143-F","article-title":"Biochemical studies on bile duct epithelial cells isolated from rat liver","volume":"10","author":"M Parola","year":"1990","journal-title":"J Hepatol"},{"issue":"04","key":"ref33","first-page":"G749","article-title":"Glutathione depletion is associated with decreased Bcl-2 expression and increased apoptosis in cholangiocytes","volume":"275","author":"A Celli","year":"1998","journal-title":"Am J Physiol"},{"issue":"01","key":"ref34","doi-asserted-by":"crossref","first-page":"e00211","DOI":"10.1002\/prp2.211","article-title":"Role of endoplasmic reticulum stress in drug-induced toxicity","volume":"4","author":"F Foufelle","year":"2016","journal-title":"Pharmacol Res Perspect"},{"issue":"04","key":"ref35","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1016\/j.cld.2009.07.004","article-title":"Endoplasmic reticulum stress and the unfolded protein response","volume":"13","author":"A Kapoor","year":"2009","journal-title":"Clin Liver Dis"},{"issue":"04","key":"ref36","doi-asserted-by":"crossref","first-page":"488","DOI":"10.2478\/s11658-006-0040-4","article-title":"Endoplasmic reticulum stress and apoptosis","volume":"11","author":"J Faitova","year":"2006","journal-title":"Cell Mol Biol Lett"},{"issue":"04","key":"ref37","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1038\/sj.cdd.4401364","article-title":"Caspase-12: an overview","volume":"11","author":"M Lamkanfi","year":"2004","journal-title":"Cell Death Differ"},{"key":"ref38","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1126\/science.1081208","article-title":"BAX and BAK regulation of endoplasmic reticulum Ca2+: a control point for apoptosis","volume":"300","author":"L Scorrano","year":"2003","journal-title":"Science"},{"issue":"04","key":"ref39","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1016\/j.jhep.2010.11.005","article-title":"Endoplasmic reticulum stress in liver disease","volume":"54","author":"H Malhi","year":"2011","journal-title":"J Hepatol"},{"issue":"09","key":"ref40","doi-asserted-by":"crossref","first-page":"984","DOI":"10.1007\/s00535-014-1033-0","article-title":"A possible involvement of endoplasmic reticulum stress in biliary epithelial autophagy and senescence in primary biliary cirrhosis","volume":"50","author":"M Sasaki","year":"2015","journal-title":"J Gastroenterol"},{"issue":"03","key":"ref41","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1159\/000450913","article-title":"Bile acids and deregulated cholangiocyte autophagy in primary biliary cholangitis","volume":"35","author":"M Sasaki","year":"2017","journal-title":"Dig Dis"},{"issue":"10","key":"ref42","first-page":"1835","article-title":"Intracellular ATP levels determine cell death fate by apoptosis or necrosis","volume":"57","author":"Y Eguchi","year":"1997","journal-title":"Cancer Res"},{"issue":"05","key":"ref43","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1089\/152308602760598918","article-title":"Role of mitochondrial inner membrane permeabilization in necrotic cell death, apoptosis, and autophagy","volume":"4","author":"J J Lemasters","year":"2002","journal-title":"Antioxid Redox Signal"},{"issue":"03","key":"ref44","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1016\/S0006-291X(03)00618-1","article-title":"Mitochondrial permeability transition: a common pathway to necrosis and apoptosis","volume":"304","author":"J S Kim","year":"2003","journal-title":"Biochem Biophys Res Commun"},{"issue":"04","key":"ref45","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1055\/s-2007-991516","article-title":"Cholangiocyte injury and ductopenic syndromes","volume":"27","author":"X Xia","year":"2007","journal-title":"Semin Liver Dis"},{"key":"ref46","doi-asserted-by":"crossref","first-page":"164329","DOI":"10.1155\/2012\/164329","article-title":"Ischemia-reperfusion injury and ischemic-type biliary lesions following liver transplantation","volume":"2012","author":"R Cursio","year":"2012","journal-title":"J Transplant"},{"issue":"01","key":"ref47","doi-asserted-by":"crossref","first-page":"G182","DOI":"10.1152\/ajpgi.2001.281.1.G182","article-title":"Regression of cholangiocyte proliferation after cessation of ANIT feeding is coupled with increased apoptosis","volume":"281","author":"G Lesage","year":"2001","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"issue":"04","key":"ref48","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1111\/j.1872-034X.2007.00049.x","article-title":"Amniotic epithelial cell-derived cholangiocytes in experimental cholestatic ductal hyperplasia","volume":"37","author":"Y Moritoki","year":"2007","journal-title":"Hepatol Res"},{"issue":"01","key":"ref49","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/S0300-483X(01)00459-0","article-title":"Role of MRP2 and GSH in intrahepatic cycling of toxins","volume":"167","author":"C G Dietrich","year":"2001","journal-title":"Toxicology"},{"issue":"02","key":"ref50","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1093\/toxsci\/kfp020","article-title":"ANIT-induced intrahepatic cholestasis alters hepatobiliary transporter expression via Nrf2-dependent and independent signaling","volume":"108","author":"Y Tanaka","year":"2009","journal-title":"Toxicol Sci"},{"issue":"01","key":"ref51","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/S0168-8278(05)80476-3","article-title":"Antibiotic-associated acute vanishing bile duct syndrome: a pattern associated with severe, prolonged, intrahepatic cholestasis","volume":"20","author":"M H Davies","year":"1994","journal-title":"J Hepatol"},{"issue":"06","key":"ref52","doi-asserted-by":"crossref","first-page":"694","DOI":"10.1021\/tx0002435","article-title":"Indirect cytotoxicity of flucloxacillin toward human biliary epithelium via metabolite formation in hepatocytes","volume":"14","author":"F Lakehal","year":"2001","journal-title":"Chem Res Toxicol"},{"issue":"06","key":"ref53","doi-asserted-by":"crossref","first-page":"1498","DOI":"10.1002\/hep.510300619","article-title":"Phase I and phase II drug-metabolizing enzymes are expressed and heterogeneously distributed in the biliary epithelium","volume":"30","author":"F Lakehal","year":"1999","journal-title":"Hepatology"},{"issue":"04","key":"ref54","doi-asserted-by":"crossref","first-page":"1377","DOI":"10.1002\/hep.24229","article-title":"Drug-induced cholestasis","volume":"53","author":"M S Padda","year":"2011","journal-title":"Hepatology"},{"issue":"11","key":"ref55","first-page":"1232","article-title":"Drug and toxin-induced bile duct disorders","volume":"15","author":"A P Geubel","year":"2000","journal-title":"J Gastroenterol Hepatol"},{"issue":"03","key":"ref56","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1016\/S1089-3261(02)00025-9","article-title":"Immune-mediated drug-induced liver disease","volume":"6","author":"Z X Liu","year":"2002","journal-title":"Clin Liver Dis"},{"issue":"01","key":"ref57","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.tox.2005.07.015","article-title":"Immunochemical detection of flucloxacillin adduct formation in livers of treated rats","volume":"216","author":"M A Carey","year":"2005","journal-title":"Toxicology"},{"issue":"06","key":"ref58","doi-asserted-by":"crossref","first-page":"720","DOI":"10.1002\/prca.200800222","article-title":"Characterisation of flucloxacillin and 5-hydroxymethyl flucloxacillin haptenated HSA in vitro and in vivo","volume":"3","author":"R E Jenkins","year":"2009","journal-title":"Proteomics Clin Appl"},{"issue":"10","key":"ref59","doi-asserted-by":"crossref","first-page":"1762","DOI":"10.1021\/acs.chemrestox.6b00253","article-title":"Amoxicillin and clavulanate form chemically and immunologically distinct multiple haptenic structures in patients","volume":"29","author":"X Meng","year":"2016","journal-title":"Chem Res Toxicol"},{"key":"ref60","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1016\/j.jprot.2012.09.030","article-title":"Protein haptenation by amoxicillin: high resolution mass spectrometry analysis and identification of target proteins in serum","volume":"77","author":"A Ariza","year":"2012","journal-title":"J Proteomics"},{"issue":"12","key":"ref61","first-page":"1920","article-title":"Human in vitro glutathionyl and protein adducts of carbamazepine-10,11-epoxide, a stable and pharmacologically active metabolite of carbamazepine","volume":"33","author":"H Z Bu","year":"2005","journal-title":"Drug Metab Dispos"},{"issue":"03","key":"ref62","doi-asserted-by":"crossref","first-page":"628","DOI":"10.1124\/mol.62.3.628","article-title":"Covalent binding of the nitroso metabolite of sulfamethoxazole leads to toxicity and major histocompatibility complex-restricted antigen presentation","volume":"62","author":"D J Naisbitt","year":"2002","journal-title":"Mol Pharmacol"},{"issue":"02","key":"ref63","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1021\/tx0002029","article-title":"Identification of a reactive metabolite of terbinafine: insights into terbinafine-induced hepatotoxicity","volume":"14","author":"S L Iverson","year":"2001","journal-title":"Chem Res Toxicol"},{"issue":"04","key":"ref64","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1038\/nrgastro.2011.22","article-title":"Mechanisms of drug-induced liver injury: from bedside to bench","volume":"8","author":"S Tujios","year":"2011","journal-title":"Nat Rev Gastroenterol Hepatol"},{"issue":"02","key":"ref65","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1016\/j.jhep.2010.10.005","article-title":"Liver antigen-presenting cells","volume":"54","author":"I N Crispe","year":"2011","journal-title":"J Hepatol"},{"issue":"04","key":"ref66","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1097\/00130832-200208000-00003","article-title":"Pharmacological interaction of drugs with antigen-specific immune receptors: the p-i concept","volume":"2","author":"W J Pichler","year":"2002","journal-title":"Curr Opin Allergy Clin Immunol"},{"issue":"05","key":"ref67","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1038\/s41575-019-0125-y","article-title":"Cholangiocyte pathobiology","volume":"16","author":"J M Banales","year":"2019","journal-title":"Nat Rev Gastroenterol Hepatol"},{"issue":"01","key":"ref68","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1002\/hep.23320","article-title":"Natural killer group 2 member D, its ligands, and liver disease: good or bad?","volume":"51","author":"B Gao","year":"2010","journal-title":"Hepatology"},{"issue":"06","key":"ref69","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1038\/icb.2008.37","article-title":"The immunobiology of cholangiocytes","volume":"86","author":"X M Chen","year":"2008","journal-title":"Immunol Cell Biol"},{"issue":"02","key":"ref70","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.4049\/jimmunol.174.2.1055","article-title":"CXC chemokine ligand 16 promotes integrin-mediated adhesion of liver-infiltrating lymphocytes to cholangiocytes and hepatocytes within the inflamed human liver","volume":"174","author":"M Heydtmann","year":"2005","journal-title":"J Immunol"},{"key":"ref71","doi-asserted-by":"crossref","first-page":"1270","DOI":"10.1016\/j.bbadis.2017.07.024","article-title":"Role of inflammation and proinflammatory cytokines in cholangiocyte pathophysiology","volume":"1864","author":"C Pinto","year":"2018","journal-title":"Biochim Biophys Acta Mol Basis Dis"},{"issue":"04","key":"ref72","doi-asserted-by":"crossref","first-page":"C788","DOI":"10.1152\/ajpcell.00250.2019","article-title":"Activated cholangiocytes release macrophage-polarizing extracellular vesicles bearing the DAMP S100A11","volume":"317","author":"T Katsumi","year":"2019","journal-title":"Am J Physiol Cell Physiol"},{"key":"ref73","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1146\/annurev.pathmechdis.3.121806.151456","article-title":"The inflammatory response to cell death","volume":"3","author":"K L Rock","year":"2008","journal-title":"Annu Rev Pathol"},{"issue":"03","key":"ref74","doi-asserted-by":"crossref","first-page":"1165","DOI":"10.1152\/physrev.00061.2009","article-title":"Hepatocyte death: a clear and present danger","volume":"90","author":"H Malhi","year":"2010","journal-title":"Physiol Rev"},{"issue":"03","key":"ref75","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1016\/j.jhep.2012.10.011","article-title":"The dynamic biliary epithelia: molecules, pathways, and disease","volume":"58","author":"S P O'Hara","year":"2013","journal-title":"J Hepatol"},{"issue":"07","key":"ref76","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1038\/ncprheum0531","article-title":"Mechanisms of disease: a \u2018DAMP\u2019 view of inflammatory arthritis","volume":"3","author":"D Foell","year":"2007","journal-title":"Nat Clin Pract Rheumatol"},{"issue":"11","key":"ref77","doi-asserted-by":"crossref","first-page":"7447","DOI":"10.4049\/jimmunol.175.11.7447","article-title":"Multiple TLRs are expressed in human cholangiocytes and mediate host epithelial defense responses to Cryptosporidium parvum via activation of NF-kappaB","volume":"175","author":"X M Chen","year":"2005","journal-title":"J Immunol"},{"issue":"05","key":"ref78","doi-asserted-by":"crossref","first-page":"1181","DOI":"10.1016\/S0016-5085(99)70404-X","article-title":"HLA association of amoxicillin-clavulanate--induced hepatitis","volume":"117","author":"M L Hautekeete","year":"1999","journal-title":"Gastroenterology"},{"issue":"03","key":"ref79","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1038\/sj.tpj.6500458","article-title":"Genome-wide pharmacogenetic investigation of a hepatic adverse event without clinical signs of immunopathology suggests an underlying immune pathogenesis","volume":"8","author":"A Kindmark","year":"2008","journal-title":"Pharmacogenomics J"},{"issue":"08","key":"ref80","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1038\/ng.632","article-title":"A genome-wide study identifies HLA alleles associated with lumiracoxib-related liver injury","volume":"42","author":"J B Singer","year":"2010","journal-title":"Nat Genet"},{"issue":"07","key":"ref81","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1038\/ng.379","article-title":"HLA-B*5701 genotype is a major determinant of drug-induced liver injury due to flucloxacillin","volume":"41","author":"A K Daly","year":"2009","journal-title":"Nat Genet"},{"issue":"01","key":"ref82","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1053\/j.gastro.2011.04.001","article-title":"Susceptibility to amoxicillin-clavulanate-induced liver injury is influenced by multiple HLA class I and II alleles","volume":"141","author":"M I Lucena","year":"2011","journal-title":"Gastroenterology"},{"key":"ref83","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1007\/s10354-008-0592-1","article-title":"Lessons from the toxic bile concept for the pathogenesis and treatment of cholestatic liver diseases","volume":"158","author":"M Trauner","year":"2008","journal-title":"Wien Med Wochenschr"},{"key":"ref84","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1016\/j.lfs.2018.12.044","article-title":"Cholangiocyte death in ductopenic cholestatic cholangiopathies: mechanistic basis and emerging therapeutic strategies","volume":"218","author":"S Salas-Silva","year":"2019","journal-title":"Life Sci"},{"issue":"01","key":"ref85","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1159\/000324687","article-title":"Biliary bicarbonate secretion constitutes a protective mechanism against bile acid-induced injury in man","volume":"29","author":"S Hohenester","year":"2011","journal-title":"Dig Dis"},{"issue":"04","key":"ref86","doi-asserted-by":"crossref","first-page":"1157","DOI":"10.1002\/hep.22485","article-title":"A mutation in the canalicular phospholipid transporter gene, ABCB4, is associated with cholestasis, ductopenia, and cirrhosis in adults","volume":"48","author":"D Gotthardt","year":"2008","journal-title":"Hepatology"},{"key":"ref87","first-page":"G267","article-title":"Bile secretion of sulfated glycolithocholic acid is required for its cholestatic action in rats","volume":"262","author":"F Kuipers","year":"1992","journal-title":"Am J Physiol"},{"issue":"06","key":"ref88","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1007\/BF01540169","article-title":"Liver injury from cyclosporine A","volume":"35","author":"C Kassianides","year":"1990","journal-title":"Dig Dis Sci"},{"issue":"02","key":"ref89","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1016\/0016-5085(93)90735-U","article-title":"Abnormal expression of anion exchanger genes in primary biliary cirrhosis","volume":"105","author":"J Prieto","year":"1993","journal-title":"Gastroenterology"},{"issue":"06","key":"ref90","doi-asserted-by":"crossref","first-page":"1038","DOI":"10.1016\/j.jhep.2008.07.027","article-title":"Genetic factors of susceptibility and of severity in primary biliary cirrhosis","volume":"49","author":"R Poupon","year":"2008","journal-title":"J Hepatol"},{"key":"ref91","doi-asserted-by":"crossref","first-page":"1374","DOI":"10.1016\/j.bbadis.2017.07.023","article-title":"Pathophysiologic implications of innate immunity and autoinflammation in the biliary epithelium","volume":"1864","author":"M Strazzabosco","year":"2018","journal-title":"Biochim Biophys Acta Mol Basis Dis"},{"issue":"03","key":"ref92","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1053\/gast.2003.50100","article-title":"Cytokine-stimulated nitric oxide production inhibits adenylyl cyclase and cAMP-dependent secretion in cholangiocytes","volume":"124","author":"C Spirl\u00ec","year":"2003","journal-title":"Gastroenterology"},{"issue":"01","key":"ref93","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1111\/liv.14271","article-title":"Diagnostic and prognostic assessment of suspected drug-induced liver injury in clinical practice","volume":"40","author":"R J Andrade","year":"2020","journal-title":"Liver Int"},{"issue":"03","key":"ref94","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1016\/j.jhep.2016.05.003","article-title":"Definition and risk factors for chronicity following acute idiosyncratic drug-induced liver injury","volume":"65","author":"I Medina-Caliz","year":"2016","journal-title":"J Hepatol"},{"issue":"03","key":"ref95","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1007\/s11901-018-0411-0","article-title":"Long-term outcomes after drug-induced liver injury","volume":"17","author":"P H Hayashi","year":"2018","journal-title":"Curr Hepatol Rep"},{"issue":"02","key":"ref96","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/j.cld.2012.11.002","article-title":"Drug-induced cholestasis","volume":"17","author":"E S Bjornsson","year":"2013","journal-title":"Clin Liver Dis"},{"issue":"03","key":"ref97","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1055\/s-0039-1685519","article-title":"Assessment of Serious acute and chronic idiosyncratic drug-induced liver injury in clinical practice","volume":"39","author":"F Bessone","year":"2019","journal-title":"Semin Liver Dis"},{"issue":"04","key":"ref98","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1055\/s-0029-1240005","article-title":"The pathology of drug-induced liver injury","volume":"29","author":"D E Kleiner","year":"2009","journal-title":"Semin Liver Dis"},{"issue":"03","key":"ref99","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1055\/s-2007-1007354","article-title":"Disappearing intrahepatic bile ducts: the syndromes and their mechanisms","volume":"13","author":"G M Woolf","year":"1993","journal-title":"Semin Liver Dis"},{"issue":"03","key":"ref100","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1016\/j.jhep.2016.04.032","article-title":"Biliary atresia and other cholestatic childhood diseases: advances and future challenges","volume":"65","author":"H J Verkade","year":"2016","journal-title":"J Hepatol"},{"key":"ref101","first-page":"1993","volume-title":"Polycystic kidney disease, autosomal recessive","author":"W E Sweeney","year":"2001"},{"issue":"43","key":"ref102","doi-asserted-by":"crossref","first-page":"7603","DOI":"10.3748\/wjg.v19.i43.7603","article-title":"Rare cystic liver lesions: a diagnostic and managing challenge","volume":"19","author":"A Bakoyiannis","year":"2013","journal-title":"World J Gastroenterol"},{"issue":"04","key":"ref103","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1002\/ajmg.c.30225","article-title":"Liver and kidney disease in ciliopathies","volume":"151C","author":"M Gunay-Aygun","year":"2009","journal-title":"Am J Med Genet C Semin Med Genet"},{"issue":"02","key":"ref104","first-page":"170","article-title":"The clinical presentation of Von Meyenburg complexes","volume":"15","author":"E Sinakos","year":"2011","journal-title":"Hippokratia"},{"issue":"28","key":"ref105","doi-asserted-by":"crossref","first-page":"9418","DOI":"10.3748\/wjg.v20.i28.9418","article-title":"Atypical causes of cholestasis","volume":"20","author":"K D Nguyen","year":"2014","journal-title":"World J Gastroenterol"},{"issue":"08","key":"ref106","doi-asserted-by":"crossref","first-page":"e11215","DOI":"10.5812\/hepatmon.11215","article-title":"Liver disease in cystic fibrosis: an update","volume":"13","author":"G F Parisi","year":"2013","journal-title":"Hepat Mon"},{"issue":"08","key":"ref107","doi-asserted-by":"crossref","first-page":"13529","DOI":"10.3390\/ijms150813529","article-title":"Cystic fibrosis related liver disease--another black box in hepatology","volume":"15","author":"K Staufer","year":"2014","journal-title":"Int J Mol Sci"},{"issue":"06","key":"ref108","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1016\/j.rmed.2010.01.016","article-title":"Alpha-1 antitrypsin deficiency","volume":"104","author":"E Kelly","year":"2010","journal-title":"Respir Med"},{"issue":"08","key":"ref109","doi-asserted-by":"crossref","first-page":"2136","DOI":"10.1111\/j.1572-0241.2008.01955.x","article-title":"Liver disease in alpha 1-antitrypsin deficiency: a review","volume":"103","author":"K D Fairbanks","year":"2008","journal-title":"Am J Gastroenterol"},{"issue":"03","key":"ref110","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/j.clinre.2014.03.010","article-title":"Cholestasis in the newborn and infant","volume":"38","author":"B Fischler","year":"2014","journal-title":"Clin Res Hepatol Gastroenterol"},{"issue":"01","key":"ref111","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/j.cld.2007.11.007","article-title":"Vanishing bile duct syndrome","volume":"12","author":"N S Reau","year":"2008","journal-title":"Clin Liver Dis"},{"issue":"02","key":"ref112","first-page":"193","article-title":"Idiopathic adulthood ductopenia. A cause of chronic cholestatic liver disease and biliary cirrhosis","volume":"7","author":"J Ludwig","year":"1988","journal-title":"J Hepatol"},{"key":"ref113","first-page":"515","volume-title":"Bile duct diseases","author":"Y Zen","year":"2018"},{"issue":"03","key":"ref114","doi-asserted-by":"crossref","first-page":"285","DOI":"10.4065\/73.3.285","article-title":"Idiopathic adulthood ductopenia: an update","volume":"73","author":"J Ludwig","year":"1998","journal-title":"Mayo Clin Proc"},{"issue":"04","key":"ref115","doi-asserted-by":"crossref","first-page":"1267","DOI":"10.1002\/hep.28967","article-title":"Clinical presentations and outcomes of bile duct loss caused by drugs and herbal and dietary supplements","volume":"65","author":"H L Bonkovsky","year":"2017","journal-title":"Hepatology"},{"issue":"02","key":"ref116","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1002\/hep.26709","article-title":"Hepatic histological findings in suspected drug-induced liver injury: systematic evaluation and clinical associations","volume":"59","author":"D E Kleiner","year":"2014","journal-title":"Hepatology"},{"issue":"02","key":"ref117","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1016\/0950-3528(88)90010-3","article-title":"Drug-induced cholestasis","volume":"2","author":"D Larrey","year":"1988","journal-title":"Baillieres Clin Gastroenterol"},{"issue":"02","key":"ref118","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1016\/S1089-3261(03)00028-X","article-title":"Bile duct disorders","volume":"7","author":"A P Geubel","year":"2003","journal-title":"Clin Liver Dis"},{"issue":"12","key":"ref119","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1042\/CS20110184","article-title":"Ursodeoxycholic acid in cholestasis: linking action mechanisms to therapeutic applications","volume":"121","author":"M G Roma","year":"2011","journal-title":"Clin Sci (Lond)"},{"key":"ref120","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3109\/00365529409103618","article-title":"Pharmacology of ursodeoxycholic acid, an enterohepatic drug","volume":"204","author":"A F Hofmann","year":"1994","journal-title":"Scand J Gastroenterol Suppl"},{"issue":"09","key":"ref121","doi-asserted-by":"crossref","first-page":"1498","DOI":"10.1111\/j.1572-0241.1998.00470.x","article-title":"Relationship between biliary and serum bile acids and response to ursodeoxycholic acid in patients with primary biliary cirrhosis","volume":"93","author":"K D Lindor","year":"1998","journal-title":"Am J Gastroenterol"},{"issue":"09","key":"ref122","doi-asserted-by":"crossref","first-page":"1721","DOI":"10.1194\/jlr.R900011-JLR200","article-title":"Bile acids: regulation of apoptosis by ursodeoxycholic acid","volume":"50","author":"J D Amaral","year":"2009","journal-title":"J Lipid Res"},{"issue":"03","key":"ref123","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1016\/j.cbi.2010.08.004","article-title":"Tauroursodeoxycholate counteracts hepatocellular lysis induced by tensioactive bile salts by preventing plasma membrane-micelle transition","volume":"188","author":"C L Basiglio","year":"2010","journal-title":"Chem Biol Interact"},{"issue":"02","key":"ref124","first-page":"930","article-title":"Ursodeoxycholate (UDCA) inhibits the mitochondrial membrane permeability transition induced by glycochenodeoxycholate: a mechanism of UDCA cytoprotection","volume":"272","author":"R Botla","year":"1995","journal-title":"J Pharmacol Exp Ther"},{"issue":"03","key":"ref125","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1007\/BF03401914","article-title":"Ursodeoxycholic acid may inhibit deoxycholic acid-induced apoptosis by modulating mitochondrial transmembrane potential and reactive oxygen species production","volume":"4","author":"C M Rodrigues","year":"1998","journal-title":"Mol Med"},{"issue":"12","key":"ref126","doi-asserted-by":"crossref","first-page":"2790","DOI":"10.1172\/JCI1325","article-title":"A novel role for ursodeoxycholic acid in inhibiting apoptosis by modulating mitochondrial membrane perturbation","volume":"101","author":"C M Rodrigues","year":"1998","journal-title":"J Clin Invest"},{"issue":"05","key":"ref127","doi-asserted-by":"crossref","first-page":"964","DOI":"10.1053\/jhep.2001.28510","article-title":"Tauroursodeoxycholic acid protects hepatocytes from ethanol-fed rats against tumor necrosis factor-induced cell death by replenishing mitochondrial glutathione","volume":"34","author":"A Colell","year":"2001","journal-title":"Hepatology"},{"issue":"01","key":"ref128","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1053\/jhep.2002.34511","article-title":"Ursodeoxycholic acid diminishes Fas-ligand-induced apoptosis in mouse hepatocytes","volume":"36","author":"F Azzaroli","year":"2002","journal-title":"Hepatology"},{"issue":"47","key":"ref129","doi-asserted-by":"crossref","first-page":"34250","DOI":"10.1074\/jbc.M704075200","article-title":"p53 is a key molecular target of ursodeoxycholic acid in regulating apoptosis","volume":"282","author":"J D Amaral","year":"2007","journal-title":"J Biol Chem"},{"issue":"03","key":"ref130","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1053\/jhep.2002.35441","article-title":"Effect of tauroursodeoxycholic acid on endoplasmic reticulum stress-induced caspase-12 activation","volume":"36","author":"Q Xie","year":"2002","journal-title":"Hepatology"},{"key":"ref131","doi-asserted-by":"crossref","first-page":"1137","DOI":"10.1126\/science.1128294","article-title":"Chemical chaperones reduce ER stress and restore glucose homeostasis in a mouse model of type 2 diabetes","volume":"313","author":"U Ozcan","year":"2006","journal-title":"Science"},{"issue":"06","key":"ref132","doi-asserted-by":"crossref","first-page":"1563","DOI":"10.1002\/hep.20246","article-title":"Tauroursodeoxycholic acid protects rat hepatocytes from bile acid-induced apoptosis via activation of survival pathways","volume":"39","author":"M H Schoemaker","year":"2004","journal-title":"Hepatology"},{"issue":"01","key":"ref133","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1207\/s15327914nc5101_15","article-title":"Ursodeoxycholic acid can suppress deoxycholic acid-induced apoptosis by stimulating Akt\/PKB-dependent survival signaling","volume":"51","author":"E Im","year":"2005","journal-title":"Nutr Cancer"},{"issue":"02","key":"ref134","doi-asserted-by":"crossref","first-page":"398","DOI":"10.2353\/ajpath.2006.050126","article-title":"Ca2+-dependent cytoprotective effects of ursodeoxycholic and tauroursodeoxycholic acid on the biliary epithelium in a rat model of cholestasis and loss of bile ducts","volume":"168","author":"M Marzioni","year":"2006","journal-title":"Am J Pathol"},{"issue":"05","key":"ref135","doi-asserted-by":"crossref","first-page":"G923","DOI":"10.1152\/ajpgi.00490.2005","article-title":"Coordinated induction of bile acid detoxification and alternative elimination in mice: role of FXR-regulated organic solute transporter-alpha\/beta in the adaptive response to bile acids","volume":"290","author":"G Zollner","year":"2006","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"issue":"42","key":"ref136","doi-asserted-by":"crossref","first-page":"39411","DOI":"10.1074\/jbc.M106340200","article-title":"Disrupted bile acid homeostasis reveals an unexpected interaction among nuclear hormone receptors, transporters, and cytochrome P450","volume":"276","author":"E G Schuetz","year":"2001","journal-title":"J Biol Chem"},{"issue":"01","key":"ref137","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1053\/gast.2001.25542","article-title":"Effects of ursodeoxycholic and cholic acid feeding on hepatocellular transporter expression in mouse liver","volume":"121","author":"P Fickert","year":"2001","journal-title":"Gastroenterology"},{"issue":"04","key":"ref138","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1016\/S0168-8278(03)00228-9","article-title":"Role of nuclear bile acid receptor, FXR, in adaptive ABC transporter regulation by cholic and ursodeoxycholic acid in mouse liver, kidney and intestine","volume":"39","author":"G Zollner","year":"2003","journal-title":"J Hepatol"},{"issue":"02","key":"ref139","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1016\/j.gastro.2005.05.009","article-title":"Complementary stimulation of hepatobiliary transport and detoxification systems by rifampicin and ursodeoxycholic acid in humans","volume":"129","author":"H U Marschall","year":"2005","journal-title":"Gastroenterology"},{"issue":"03","key":"ref140","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1097\/MOG.0b013e328352aab2","article-title":"The biliary HCO(3)(-) umbrella: experimental evidence revisited","volume":"28","author":"U Beuers","year":"2012","journal-title":"Curr Opin Gastroenterol"},{"issue":"01","key":"ref141","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/S0016-5085(99)70564-0","article-title":"Assessment of biliary bicarbonate secretion in humans by positron emission tomography","volume":"117","author":"J Prieto","year":"1999","journal-title":"Gastroenterology"},{"issue":"02","key":"ref142","first-page":"695","article-title":"Combination of ursodeoxycholic acid and glucocorticoids upregulates the AE2 alternate promoter in human liver cells","volume":"118","author":"F Arenas","year":"2008","journal-title":"J Clin Invest"},{"issue":"02","key":"ref143","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/0168-8278(90)90108-4","article-title":"Influence of backward perfusion on ursodeoxycholate-induced choleresis in isolated in situ rat liver","volume":"11","author":"F Perez Barriocanal","year":"1990","journal-title":"J Hepatol"},{"issue":"02","key":"ref144","doi-asserted-by":"crossref","first-page":"942","DOI":"10.1016\/0006-291X(92)91146-H","article-title":"Ursodeoxycholic acid-dependent activation of the glucocorticoid receptor","volume":"188","author":"H Tanaka","year":"1992","journal-title":"Biochem Biophys Res Commun"},{"issue":"02","key":"ref145","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1002\/hep.1840160213","article-title":"Immunomodulatory effects of ursodeoxycholic acid on immune responses","volume":"16","author":"M Yoshikawa","year":"1992","journal-title":"Hepatology"},{"issue":"01","key":"ref146","first-page":"165","article-title":"The immunosuppressive effect of ursodeoxycholic acid: a comparative in vitro study on human peripheral blood mononuclear cells","volume":"18","author":"F Lacaille","year":"1993","journal-title":"Hepatology"},{"issue":"62","key":"ref147","first-page":"596","article-title":"Ursodeoxycholic acid (UDCA) suppresses liver interleukin 2 mRNA in the cholangitis model","volume":"52","author":"S Miyaguchi","year":"2005","journal-title":"Hepatogastroenterology"},{"issue":"12","key":"ref148","doi-asserted-by":"crossref","first-page":"1259","DOI":"10.2169\/internalmedicine.42.1259","article-title":"Ursodeoxycholic acid therapy attenuated expression of adhesion molecule in primary biliary cirrhosis","volume":"42","author":"H Yokomori","year":"2003","journal-title":"Intern Med"},{"key":"ref149","doi-asserted-by":"crossref","first-page":"59","DOI":"10.3109\/00365529409103626","article-title":"Ursodeoxycholic acid therapy in treatment of primary sclerosing cholangitis","volume":"204","author":"A Stiehl","year":"1994","journal-title":"Scand J Gastroenterol Suppl"},{"issue":"02","key":"ref150","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1016\/0016-5085(92)90855-S","article-title":"Immunosuppressive properties of chenodeoxycholic and ursodeoxycholic acids in the mouse","volume":"103","author":"Y Calmus","year":"1992","journal-title":"Gastroenterology"},{"issue":"07","key":"ref151","first-page":"1456","article-title":"Drug-induced vanishing bile duct syndrome: response to ursodiol","volume":"91","author":"C B O'Brien","year":"1996","journal-title":"Am J Gastroenterol"},{"issue":"06","key":"ref152","doi-asserted-by":"crossref","first-page":"1437","DOI":"10.1002\/hep.1840200610","article-title":"Chlorpromazine-induced vanishing bile duct syndrome leading to biliary cirrhosis","volume":"20","author":"D Moradpour","year":"1994","journal-title":"Hepatology"},{"issue":"03","key":"ref153","first-page":"118","article-title":"Chlorpromazine-induced cholestatic liver disease with ductopenia","volume":"37","author":"A Chlumsk\u00e1","year":"2001","journal-title":"Cesk Patol"},{"issue":"02","key":"ref154","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1016\/j.jpeds.2004.05.027","article-title":"Acute vanishing bile duct syndrome after ibuprofen therapy in a child","volume":"145","author":"M Taghian","year":"2004","journal-title":"J Pediatr"},{"issue":"06","key":"ref155","doi-asserted-by":"crossref","first-page":"1844","DOI":"10.1016\/0016-5085(94)90830-3","article-title":"Tetracycline-induced bile duct paucity and prolonged cholestasis","volume":"107","author":"C M Hunt","year":"1994","journal-title":"Gastroenterology"},{"issue":"04","key":"ref156","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1097\/01.mpg.0000178086.44155.73","article-title":"Vanishing bile duct syndrome: amoxicillin-clavulanic acid associated intra-hepatic cholestasis responsive to ursodeoxycholic acid","volume":"41","author":"L A Smith","year":"2005","journal-title":"J Pediatr Gastroenterol Nutr"},{"key":"ref157","first-page":"239","volume-title":"Drug-induced bile duct injury","author":"A P Geubel","year":"1997"},{"issue":"01","key":"ref158","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/S0022-3476(00)90064-7","article-title":"Rapidly progressive cholestasis: an unusual reaction to amoxicillin\/clavulanic acid therapy in a child","volume":"136","author":"A Chawla","year":"2000","journal-title":"J Pediatr"},{"issue":"04","key":"ref159","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1111\/liv.13344","article-title":"Finding the cure for primary biliary cholangitis - still waiting","volume":"37","author":"A Tanaka","year":"2017","journal-title":"Liver Int"},{"issue":"01","key":"ref160","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1111\/j.1742-7843.2009.00474.x","article-title":"Vanishing bile duct syndrome associated with azithromycin in a 62-year-old man","volume":"106","author":"D Juricic","year":"2010","journal-title":"Basic Clin Pharmacol Toxicol"},{"issue":"11","key":"ref161","doi-asserted-by":"crossref","first-page":"2385","DOI":"10.1023\/A:1012351231143","article-title":"Stevens-Johnson syndrome and cholestatic hepatitis","volume":"46","author":"M S Morelli","year":"2001","journal-title":"Dig Dis Sci"},{"issue":"03","key":"ref162","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1016\/S0016-5085(98)70154-4","article-title":"Drug-associated acute-onset vanishing bile duct and Stevens-Johnson syndromes in a child","volume":"115","author":"M Srivastava","year":"1998","journal-title":"Gastroenterology"},{"issue":"01","key":"ref163","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1023\/A:1013296310944","article-title":"Efficacy of early immunosuppressive therapy in a child with carbamazepine-associated vanishing bile duct and Stevens-Johnson syndromes","volume":"47","author":"M Garcia","year":"2002","journal-title":"Dig Dis Sci"},{"issue":"04","key":"ref164","first-page":"234","article-title":"A favorable response to steroid therapy in a child with drug-associated acute vanishing bile duct syndrome and skin disorder","volume":"44","author":"H Tajiri","year":"2008","journal-title":"J Paediatr Child Health"},{"issue":"04","key":"ref165","doi-asserted-by":"crossref","first-page":"e1194","DOI":"10.1542\/peds.2013-2239","article-title":"Infliximab\/Plasmapheresis in vanishing bile duct syndrome secondary to toxic epidermal necrolysis","volume":"134","author":"J C White","year":"2014","journal-title":"Pediatrics"},{"issue":"02","key":"ref166","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1016\/S1665-2681(19)32029-0","article-title":"Vanishing bile duct syndrome in a child with toxic epidermal necrolysis: an interplay of unbalanced immune regulatory mechanisms","volume":"5","author":"W Karnsakul","year":"2006","journal-title":"Ann Hepatol"},{"issue":"03","key":"ref167","doi-asserted-by":"crossref","first-page":"834","DOI":"10.3349\/ymj.2014.55.3.834","article-title":"Ibuprofen associated acute vanishing bile duct syndrome and toxic epidermal necrolysis in an infant","volume":"55","author":"H Y Kim","year":"2014","journal-title":"Yonsei Med J"},{"issue":"06","key":"ref168","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1111\/j.1442-200X.2006.02268.x","article-title":"Vanishing bile duct syndrome with a history of erythema multiforme","volume":"48","author":"J Takeyama","year":"2006","journal-title":"Pediatr Int"},{"issue":"08","key":"ref169","doi-asserted-by":"crossref","first-page":"376","DOI":"10.4253\/wjge.v4.i8.376","article-title":"Drug associated vanishing bile duct syndrome combined with hemophagocytic lymphohistiocytosis","volume":"4","author":"H Li","year":"2012","journal-title":"World J Gastrointest Endosc"},{"issue":"45","key":"ref170","doi-asserted-by":"crossref","first-page":"6087","DOI":"10.3748\/wjg.v13.45.6087","article-title":"Mycophenolate mofetil for drug-induced vanishing bile duct syndrome","volume":"13","author":"S S Jakab","year":"2007","journal-title":"World J Gastroenterol"},{"issue":"29","key":"ref171","doi-asserted-by":"crossref","first-page":"4697","DOI":"10.3748\/wjg.14.4697","article-title":"Vanishing bile duct and Stevens-Johnson syndrome associated with ciprofloxacin treated with tacrolimus","volume":"14","author":"G Okan","year":"2008","journal-title":"World J Gastroenterol"},{"issue":"06","key":"ref172","doi-asserted-by":"crossref","first-page":"1739","DOI":"10.1002\/hep.20130","article-title":"Nomenclature of the finer branches of the biliary tree: canals, ductules, and ductular reactions in human livers","volume":"39","author":"T A Roskams","year":"2004","journal-title":"Hepatology"},{"issue":"05","key":"ref173","doi-asserted-by":"crossref","first-page":"1853","DOI":"10.1002\/hep.24613","article-title":"Ductular reactions in human liver: diversity at the interface","volume":"54","author":"A S Gouw","year":"2011","journal-title":"Hepatology"},{"issue":"02","key":"ref174","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1053\/j.gastro.2009.05.044","article-title":"Stem cells and liver regeneration","volume":"137","author":"A W Duncan","year":"2009","journal-title":"Gastroenterology"},{"issue":"02","key":"ref175","doi-asserted-by":"crossref","first-page":"C499","DOI":"10.1152\/ajpcell.00369.2007","article-title":"Small mouse cholangiocytes proliferate in response to H1 histamine receptor stimulation by activation of the IP3\/CaMK I\/CREB pathway","volume":"295","author":"H Francis","year":"2008","journal-title":"Am J Physiol Cell Physiol"},{"issue":"02","key":"ref176","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1016\/j.ajpath.2010.09.043","article-title":"Regulation of biliary proliferation by neuroendocrine factors: implications for the pathogenesis of cholestatic liver diseases","volume":"178","author":"M K Munshi","year":"2011","journal-title":"Am J Pathol"},{"issue":"02","key":"ref177","doi-asserted-by":"crossref","first-page":"155","DOI":"10.3727\/105221616X692568","article-title":"Regulators of cholangiocyte proliferation","volume":"17","author":"C Hall","year":"2017","journal-title":"Gene Expr"},{"issue":"22","key":"ref178","doi-asserted-by":"crossref","first-page":"3537","DOI":"10.3748\/wjg.v12.i22.3537","article-title":"Estrogens and the pathophysiology of the biliary tree","volume":"12","author":"D Alvaro","year":"2006","journal-title":"World J Gastroenterol"},{"issue":"01","key":"ref179","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1053\/j.gastro.2006.07.023","article-title":"Proliferating cholangiocytes: a neuroendocrine compartment in the diseased liver","volume":"132","author":"D Alvaro","year":"2007","journal-title":"Gastroenterology"},{"issue":"07","key":"ref180","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1101\/gad.207803.112","article-title":"Robust cellular reprogramming occurs spontaneously during liver regeneration","volume":"27","author":"K Yanger","year":"2013","journal-title":"Genes Dev"},{"issue":"03","key":"ref181","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1002\/hep.20600","article-title":"Transdifferentiation of rat hepatocytes into biliary cells after bile duct ligation and toxic biliary injury","volume":"41","author":"G K Michalopoulos","year":"2005","journal-title":"Hepatology"},{"issue":"05","key":"ref182","doi-asserted-by":"crossref","first-page":"1468","DOI":"10.1016\/j.ajpath.2014.01.005","article-title":"Hepatocytes, rather than cholangiocytes, can be the major source of primitive ductules in the chronically injured mouse liver","volume":"184","author":"S Sekiya","year":"2014","journal-title":"Am J Pathol"},{"issue":"04","key":"ref183","doi-asserted-by":"crossref","first-page":"1828","DOI":"10.1002\/hep.30250","article-title":"From hepatocyte to cholangiocyte: the remarkable potential of transdifferentiation to treat cholestatic diseases","volume":"69","author":"B Kamath","year":"2019","journal-title":"Hepatology"},{"key":"ref184","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1038\/s41586-018-0075-5","article-title":"De novo formation of the biliary system by TGF\u03b2-mediated hepatocyte transdifferentiation","volume":"557","author":"J R Schaub","year":"2018","journal-title":"Nature"},{"issue":"06","key":"ref185","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1111\/j.1600-0676.1989.tb00426.x","article-title":"A cytokeratin-immunohistochemical study of focal nodular hyperplasia of the liver: further evidence that ductular metaplasia of hepatocytes contributes to ductular \u201cproliferation\u201d","volume":"9","author":"P van Eyken","year":"1989","journal-title":"Liver"},{"issue":"05","key":"ref186","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1016\/j.stem.2014.09.008","article-title":"Bipotential adult liver progenitors are derived from chronically injured mature hepatocytes","volume":"15","author":"B D Tarlow","year":"2014","journal-title":"Cell Stem Cell"},{"key":"ref187","doi-asserted-by":"crossref","first-page":"39990","DOI":"10.1038\/srep39990","article-title":"Progressive induction of hepatocyte progenitor cells in chronically injured liver","volume":"7","author":"N Tanimizu","year":"2017","journal-title":"Sci Rep"},{"issue":"04","key":"ref188","first-page":"403","article-title":"Characterization of ductular hepatocytes in end-stage cirrhosis","volume":"114","author":"A M Vandersteenhoven","year":"1990","journal-title":"Arch Pathol Lab Med"},{"key":"ref189","doi-asserted-by":"crossref","first-page":"e15034","DOI":"10.7554\/eLife.15034","article-title":"Heterogeneity and stochastic growth regulation of biliary epithelial cells dictate dynamic epithelial tissue remodeling","volume":"5","author":"K Kamimoto","year":"2016","journal-title":"eLife"},{"issue":"06","key":"ref190","doi-asserted-by":"crossref","first-page":"2094","DOI":"10.1016\/j.ajpath.2012.08.034","article-title":"Recovery of mature hepatocytic phenotype following bile ductular transdifferentiation of rat hepatocytes in vitro","volume":"181","author":"M Sone","year":"2012","journal-title":"Am J Pathol"},{"issue":"05","key":"ref191","doi-asserted-by":"crossref","first-page":"1702","DOI":"10.1002\/hep.22221","article-title":"Mechanisms of hepatocyte growth factor-mediated and epidermal growth factor-mediated signaling in transdifferentiation of rat hepatocytes to biliary epithelium","volume":"47","author":"P B Limaye","year":"2008","journal-title":"Hepatology"},{"issue":"04","key":"ref192","doi-asserted-by":"crossref","first-page":"1077","DOI":"10.1016\/S0002-9440(10)62328-0","article-title":"Transdifferentiation of mature rat hepatocytes into bile duct-like cells in vitro","volume":"166","author":"Y Nishikawa","year":"2005","journal-title":"Am J Pathol"},{"issue":"06","key":"ref193","doi-asserted-by":"crossref","first-page":"2469","DOI":"10.1002\/hep.26254","article-title":"Canonical Notch2 signaling determines biliary cell fates of embryonic hepatoblasts and adult hepatocytes independent of Hes1","volume":"57","author":"P Jeliazkova","year":"2013","journal-title":"Hepatology"},{"issue":"08","key":"ref194","doi-asserted-by":"crossref","first-page":"2911","DOI":"10.1172\/JCI63212","article-title":"Cholangiocarcinomas can originate from hepatocytes in mice","volume":"122","author":"B Fan","year":"2012","journal-title":"J Clin Invest"},{"issue":"06","key":"ref195","doi-asserted-by":"crossref","first-page":"1324","DOI":"10.1016\/j.cell.2014.03.060","article-title":"Hippo pathway activity influences liver cell fate","volume":"157","author":"D Yimlamai","year":"2014","journal-title":"Cell"},{"issue":"05","key":"ref196","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1089\/cell.2014.0032","article-title":"Hepatocyte-ductal transdifferentiation is mediated by reciprocal repression of SOX9 and C\/EBP\u03b1","volume":"16","author":"K E O'Neill","year":"2014","journal-title":"Cell Reprogram"},{"issue":"01","key":"ref197","doi-asserted-by":"crossref","first-page":"51","DOI":"10.3727\/105221617X15124876321401","article-title":"Oct4 is crucial for transdifferentiation of hepatocytes to biliary epithelial cells in an in vitro organoid culture model","volume":"18","author":"M Doffou","year":"2018","journal-title":"Gene Expr"},{"issue":"02","key":"ref198","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/j.bpg.2011.02.001","article-title":"Fibrosis in autoimmune and cholestatic liver disease","volume":"25","author":"M Penz-\u00d6sterreicher","year":"2011","journal-title":"Best Pract Res Clin Gastroenterol"},{"issue":"06","key":"ref199","doi-asserted-by":"crossref","first-page":"2040","DOI":"10.1002\/hep.22623","article-title":"Pathobiology of biliary epithelia and cholangiocarcinoma: proceedings of the Henry M. and Lillian Stratton Basic Research Single-Topic Conference","volume":"48","author":"A E Sirica","year":"2008","journal-title":"Hepatology"},{"issue":"07","key":"ref200","doi-asserted-by":"crossref","first-page":"1855","DOI":"10.1053\/j.gastro.2011.04.030","article-title":"Polycystic liver diseases: congenital disorders of cholangiocyte signaling","volume":"140","author":"M Strazzabosco","year":"2011","journal-title":"Gastroenterology"}],"container-title":["Seminars in Liver Disease"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.thieme-connect.de\/products\/ejournals\/pdf\/10.1055\/s-0041-1729972.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,4]],"date-time":"2023-11-04T22:56:21Z","timestamp":1699138581000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.thieme-connect.de\/DOI\/DOI?10.1055\/s-0041-1729972"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,6,15]]},"references-count":200,"journal-issue":{"issue":"03","published-online":{"date-parts":[[2021,7,28]]},"published-print":{"date-parts":[[2021,8]]}},"URL":"https:\/\/doi.org\/10.1055\/s-0041-1729972","archive":["Portico","CLOCKSS"],"relation":{},"ISSN":["0272-8087","1098-8971"],"issn-type":[{"value":"0272-8087","type":"print"},{"value":"1098-8971","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,6,15]]}}}